|
|
Bruker Corporation (BRKR) |
|
|
|
Bruker's Yearly Income from Continued Operations Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
|
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
|
BRKR Annual Income from Cont. Operations Growth |
2022
|
2021
|
2019
|
2018
|
2017
|
Y / Y Annual Income from Cont. Operations Change |
6.38 % |
41.72 % |
9.39 % |
125.4 % |
-48.03 % |
Annual Income from Cont. Operations (in millions $) |
$298.50 |
$280.60 |
$198.00 |
$181.00 |
$80.30 |
Annual Income from Cont. Operations Growth
Comment |
Bruker's Annual Income from Cont. Operations for the fiscal year ended 2022, increased by 6.38% to $298.50 millions, from $280.60 millions achieved a year ago. Bruker's 2022 Annual Income from Cont. Operations performance marks a slow down, from 41.72 % achieved in the fiscal year 2021.
Bruker Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2022 Annual Income from Cont. Operations within Healthcare Sector | Y/Y Income from Continued Operations Growth % | 2022 Annual Income from Cont. Operations | Sinovac Biotech Ltd | -99.39 % | $ 88.131 millions | Koninklijke Philips Nv | | | |